These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3582088)

  • 21. Exercise in insulin-dependent diabetes mellitus: the effect of continuous insulin infusion using the subcutaneous, intravenous, and intraperitoneal sites.
    Gooch BR; Abumrad NN; Robinson RP; Petrik M; Campbell D; Crofford OB
    Diabetes Care; 1983; 6(2):122-8. PubMed ID: 6343016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained metabolic control and low rates of severe hypoglycaemic episodes in preschool diabetic children treated with continuous subcutaneous insulin infusion.
    Pańkowska E; Szypowska A; Lipka M; Skórka A
    Acta Paediatr; 2007 Jun; 96(6):881-4. PubMed ID: 17537017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of continuous subcutaneous insulin infusion in patients with cystic fibrosis related diabetes: three case reports.
    Sulli N; Bertasi S; Zullo S; Shashaj B
    J Cyst Fibros; 2007 May; 6(3):237-40. PubMed ID: 16973423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Congenital generalized lipodystrophy in children].
    Letova EK
    Pediatriia; 1982; (9):64-6. PubMed ID: 7145575
    [No Abstract]   [Full Text] [Related]  

  • 25. Subcutaneous insulin order sets and protocols: effective design and implementation strategies.
    Maynard G; Wesorick DH; O'Malley C; Inzucchi SE;
    J Hosp Med; 2008 Sep; 3(5 Suppl):29-41. PubMed ID: 18951386
    [No Abstract]   [Full Text] [Related]  

  • 26. Lipodystrophies: adipose tissue disorders with severe metabolic implications.
    Cortés VA; Fernández-Galilea M
    J Physiol Biochem; 2015 Sep; 71(3):471-8. PubMed ID: 25833179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features of brittle diabetic patients unresponsive to optimized subcutaneous insulin therapy (continuous subcutaneous insulin infusion).
    Pickup J; Williams G; Johns P; Keen H
    Diabetes Care; 1983; 6(3):279-84. PubMed ID: 6409572
    [No Abstract]   [Full Text] [Related]  

  • 28. [New aspects of insulin therapy].
    Andreev D
    Vutr Boles; 1985; 24(6):49-54. PubMed ID: 3913147
    [No Abstract]   [Full Text] [Related]  

  • 29. Congenital generalized lipodystrophy.
    Kaplan BS
    S Afr Med J; 1970 Aug; 44(33):945-8. PubMed ID: 4318181
    [No Abstract]   [Full Text] [Related]  

  • 30. [A case of congenital total lipodystrophy--metabolic and post-mortem examination (author's transl)].
    Togawa K; Naito C; Terayama I; Iimura Y; Ogata E
    Nihon Naika Gakkai Zasshi; 1974 Feb; 63(2):153-62. PubMed ID: 4471726
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of diabetes mellitus using an external insulin pump in clinical practice.
    Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B
    Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies in congenital generalized lipodystrophy. IV. Effect of muscular exercise on carbohydrate and fat metabolism including plasma levels of IRI and HGH.
    Oseid S; Pruett ED
    Acta Endocrinol (Copenh); 1976 Dec; 83(4):839-55. PubMed ID: 1036653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replacement treatment with insulin in diabetes mellitus: problems and promise.
    Dupre J; Champion MC; Rodger NW
    Clin Invest Med; 1982; 5(2-3):109-19. PubMed ID: 6749365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.
    Petersen KF; Oral EA; Dufour S; Befroy D; Ariyan C; Yu C; Cline GW; DePaoli AM; Taylor SI; Gorden P; Shulman GI
    J Clin Invest; 2002 May; 109(10):1345-50. PubMed ID: 12021250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A guideline for the use of variable rate intravenous insulin infusion in medical inpatients.
    George S; Dale J; Stanisstreet D; ;
    Diabet Med; 2015 Jun; 32(6):706-13. PubMed ID: 25980646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of diabetes mellitus using an external insulin pump: the state of the art.
    Hanaire H; Lassmann-Vague V; Jeandidier N; Renard E; Tubiana-Rufi N; Vambergue A; Raccah D; Pinget M; Guerci B
    Diabetes Metab; 2008 Sep; 34(4 Pt 2):401-23. PubMed ID: 18951116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSII: an aid to patient selection and training.
    Wilson DP; Endres RK
    Diabetes Care; 1981; 4(6):659-60. PubMed ID: 7347677
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined continuous subcutaneous insulin infusion and multiple subcutaneous injections in type I diabetic patients.
    Schiffrin A; Belmonte M
    Diabetes Care; 1981; 4(6):595-600. PubMed ID: 6751734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Difficult to manage diabetes mellitus associated with generalized congenital lipodystrophy. Report of two cases].
    Cardona-Hernández R; Suárez-Ortega L; Torres M
    An Pediatr (Barc); 2011 Feb; 74(2):126-30. PubMed ID: 21168376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin receptor evaluation in congenital generalized lipodystrophy. Case report of an infant.
    Aricò M; Ricordi A; Caselli D; Aschei M; Colombo A; Fratino P
    Helv Paediatr Acta; 1987 Oct; 42(2-3):167-71. PubMed ID: 3319972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.